Biotalys wins California registration for EVOCA biofungicide, bolstering EVOCA NG path

• Biotalys won California registration for EVOCA, its protein-based biofungicide, clearing one of the toughest US pesticide markets.
• The decision strengthens the regulatory path for lead asset EVOCA NG, which uses the same active ingredient and building blocks.
• Biotalys targets a 2029 US launch for EVOCA NG, building on prior EPA approval plus Florida registration.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GIMV NV published the original content used to generate this news brief on September 02, 2026, and is solely responsible for the information contained therein.